Beyond Air(XAIR) - 2023 Q3 - Earnings Call Transcript

Moving on to Beyond Cancer. Progress over the last 15 months since the money raised has been very strong. The Phase 1a human clinical study is ongoing with our current belief that we will be releasing topline data later this calendar year. Our first publication is out with another expected later this year. Our preclinical team is quite active with data expected at several medical conferences this year and we have already shown a doubling of survival in animals when we added our UNO therapy to anti-PD-1 ther ...